Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Dec 2021 – 20 Aug 2026, limited by Bandhan Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Multi Cap Fund | Nifty 500 |
|---|---|---|
| 03 Dec 2021 | ₹100.00 | ₹100.00 |
| 25 Apr 2022 | ₹99.20 | ₹98.77 |
| 16 Sep 2022 | ₹105.43 | ₹102.61 |
| 06 Feb 2023 | ₹106.55 | ₹100.52 |
| 30 Jun 2023 | ₹117.42 | ₹110.59 |
| 20 Nov 2023 | ₹127.68 | ₹118.29 |
| 12 Apr 2024 | ₹151.41 | ₹139.64 |
| 02 Sep 2024 | ₹176.40 | ₹159.94 |
| 23 Jan 2025 | ₹158.66 | ₹144.98 |
| 16 Jun 2025 | ₹170.97 | ₹155.46 |
| 06 Nov 2025 | ₹172.57 | ₹158.27 |
| 30 Mar 2026 | ₹150.32 | ₹138.18 |
| 20 Aug 2026 | ₹177.07 | ₹158.27 |
| Metric | Bandhan · Regular NAV ₹17.73 Very High risk ★★★☆☆ | Category median Multi Cap Fund · 33 funds |
|---|---|---|
| +2.91% | +8.06% | |
| +13.55% | +15.20% | |
| — | +14.26% | |
| — | +14.26% | |
| +12.89% | +14.72% | |
| +12.27% | — | |
| +17.13% | +16.83% | |
| — | +15.79% | |
| — | +14.87% | |
| Risk | ||
| 13.63% | 14.84% | |
| 0.52 | 0.56 | |
| 0.70 | 0.76 | |
| -18.79% | -20.32% | |
| Nifty 500 | — | |
| +1.07% | +2.81% | |
| 1.00 | 1.01 | |
| 101.7% | 110.1% | |
| 95.9% | 95.9% | |
| 2.28% | 2.21% | |
| ₹2,886Cr | ₹3,513Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 57% | 56% | |
| Harshal Joshi | — | |
| 03 Dec 2021 | — | |
| 111 | — | |
| 28.2% | — | |
| 3.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.